Clinical Trial Results:
Trattamento dell’epatocarcinoma (HCC) mediante chemioembolizzazione (TACE) selettiva tradizionale versus TACE selettiva con microsfere caricate con Doxorubicina: studio monocentrico, randomizzato, in aperto, controllato.
Summary
|
|
EudraCT number |
2006-003034-15 |
Trial protocol |
IT |
Global completion date |
19 Dec 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
14 Jul 2022
|
First version publication date |
14 Jul 2022
|
Other versions |
|
Summary report(s) |
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.